Skip to main content

Table 3 Choice of pharmacological treatment strategies, in response to the case vignettes, compared between respiratory medicine (RM) and palliative care (PC) physicians

From: Do guidelines influence breathlessness management in advanced lung diseases? A multinational survey of respiratory medicine and palliative care physicians

 

COPD

fILD

LC

RM (n = 336)

PC (n = 95)

Specialties compared (χ2)

p value

RM (n = 324)

PC (n = 87)

Specialties compared (χ2)

p value

RM (n = 300)

PC (n = 102)

Specialties compared (χ2)

p value

Opioids

Often or always

132 (39%)

87 (92%)

p < 0.001

117 (36%)

72 (83%)

p < 0.001

227 (76%)

97 (95%)

p < 0.001

Rarely or sometimes

150 (45%)

7 (7%)

148 (46%)

14 (16%)

59 (20%)

5 (5%)

Never

54 (16%)

1 (1%)

59 (18%)

1 (1%)

14 (5%)

–

Benzodiazepines

Often or always

34 (10%)

31 (33%)

p < 0.001

40 (12%)

22 (25%)

p < 0.001

108 (36%)

47 (46%)

p = 0.001

Rarely or sometimes

194 (58%)

60 (63%)

181 (56%)

58 (67%)

142 (47%)

52 (51%)

Never

108 (32%)

4 (4%)

103 (32%)

7 (8%)

50 (17%)

3 (3%)

Antidepressants

Often or always

62 (19%)

10 (11%)

p = 0.010

39 (12%)

11 (13%)

p = 0.298

63 (21%)

15 (15%)

p = 0.379

Rarely or sometimes

201 (60%)

73 (77%)

175 (54%)

54 (62%)

173 (58%)

63 (62%)

Never

73 (22%)

12 (13%)

110 (34%)

22 (25%)

64 (21%)

24 (24%)

  1. Percentages > or < 100% are due to rounding
  2. COPD, Chronic Obstructive Pulmonary Disease; fILD, Fibrotic Interstitial Lung Disease; LC, Lung Cancer; PC, Palliative Care; RM, Respiratory Medicine